FILTER
FILTERED INTERVIEW RESULTS
John Patrick Oroho
EXECUTIVE VICE PRESIDENT AND CHIEF STRATEGY OFFICER, PORZIO LIFE SCIENCES, LLC
Porzio Life Sciences, LLC (PorzioLS) is a provider of compliance operations products and services for the life sciences industry, and a wholly‐owned subsidiary of the Porzio, Bromberg & Newman, P.C. law firm.
Ciara Kennedy
PRESIDENT AND CEO, AMPLYX PHARMACEUTICALS
Amplyx Pharmaceuticals has a near-term focus on deadly fungal pathogens in vulnerable, immune-compromised patients.
Nataliya Katsnelson
DIRECTOR – BUSINESS DEVELOPMENT, GLOBAL CLINICAL TRIALS
GCT is a CRO providing clinical development services for drugs and medical devices, with operations focused on Central and Eastern Europe, Russia and India.
Sam Taylor
PRESIDENT, THE NORTH CAROLINA BIOSCIENCES ORGANIZATION (NCBIO)
NCBIO is dedicated to promoting the future growth and development of North Carolina’s bioscience industry.
Hugh Davis
CHIEF BUSINESS OFFICER, FRONTAGE LABORATORIES
Frontage Laboratories operates as a contract research organization that provides scientific and analytical services to pharmaceutical and biotech companies.
Olivier Safir
CEO, PACT AND PARTNERS, LLC
Pact and Partners is an executive search firm dedicated to the life sciences industry since 1987.
Christopher Molineaux
PRESIDENT & CEO, LIFE SCIENCES PENNSYLVANIA
Founded in 1989, Life Sciences Pennsylvania (LSPA) is a statewide trade association for Pennsylvania’s life sciences industry.
Nicole Bishop
CEO AND FOUNDER, QUARTOLIO
Quartolio is an AI-powered knowledge management platform that accelerates research by connecting the dots across scholarly data, documents and discussions.
Mike Guerra
PRESIDENT & CEO, CALIFORNIA LIFE SCIENCES ASSOCIATION (CLSA)
California Life Sciences Association (CLSA) is the trade association representing California’s life sciences sector.
Jim Neal
CEO, XOMA
XOMA is a royalty monetizer acquiring early clinical-stage milestone and royalty assets.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2024 - Digital Interactive
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
